BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

2.120

-0.190 (-8.23%)

At close: Mar 28, 2025, 4:00 PM

2.090

-0.030 (-1.42%)

After-hours: Mar 28, 2025, 7:57 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $6.58 million as of March 28, 2025. Its market cap has decreased by -92.46% in one year.

Market Cap

6.58M

Enterprise Value

71.16M

1-Year Change

-92.46%

Ranking

#5197

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $6.58M, a decrease of -96.19%. That is a compound annual growth rate of -37.05%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	6.58M	-64.56%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	738.61B
UnitedHealth Group	472.03B
Johnson & Johnson	394.52B
AbbVie	363.15B
Novo Nordisk	305.46B
AstraZeneca	229.16B
Abbott Laboratories	226.88B
Merck & Co.	225.40B

Market Cap Rankings